- 36
- 42 205
Cardio-Ed
Registrace 14. 10. 2020
I am Dr Shailesh Singh, a Cardiologist from India.
This channel Cardio Ed is for medical students, internal medicine residents, family medicine residents, cardiology residents, and fellows as well as practitioners of General Cardiology, Interventional Cardiology, Cardiac imaging, Internal Medicine and Family Medicine who are interested in learning and re-learning the concepts of Cardiology.
If you want to get updated about the recent advances in the field of Cardiology OR you want to revise the core Cardiology OR even if you are a newbie and you are going for a first reading of the subject, these lectures/ presentations might be useful for you.
We talk about various subspecialties of cardiology on this channel.
Any discussion, disagreement, counter-arguement, and query is welcome.
Cardio Ed is available on all major podcast platforms. You can stay updated on the go. Search for Cardio Ed on your favourite podcast platforms. Links to the podcast are give below.
Contrast nephropathy/ Contrast associated Acute Kidney Injury
A discussion on complication of #contrast-induced #nephropathy; its diagnosis, long-term sequela, pathophysiology, risk factors, and risk reduction strategies.
Contrast induced or contrast associated acute kidney injury is one of the important complications seen after percutaneous interventions.
In this video we discuss how we can prevent #CIN by using - Before the procedure: Hydration, High dose statin, Discontinuation of nephrotoxic medications. During the procedure: Decrease contrast volume
Iso-osmolar contrast, Prevent hypotension. After the procedure:
Hydration. And the recent advances in prevention of contrast associated acute kidney
injury #AKI.
Other discussions in Interventional Cardiology-
In stent restenosis
czcams.com/video/4poE6E5yZJc/video.html
Revascularization in stable CAD
czcams.com/video/ZIxUpDY32MQ/video.html
Fractional Flow Reserve
czcams.com/video/qwn12YDZKWs/video.html
Contrast induced or contrast associated acute kidney injury is one of the important complications seen after percutaneous interventions.
In this video we discuss how we can prevent #CIN by using - Before the procedure: Hydration, High dose statin, Discontinuation of nephrotoxic medications. During the procedure: Decrease contrast volume
Iso-osmolar contrast, Prevent hypotension. After the procedure:
Hydration. And the recent advances in prevention of contrast associated acute kidney
injury #AKI.
Other discussions in Interventional Cardiology-
In stent restenosis
czcams.com/video/4poE6E5yZJc/video.html
Revascularization in stable CAD
czcams.com/video/ZIxUpDY32MQ/video.html
Fractional Flow Reserve
czcams.com/video/qwn12YDZKWs/video.html
zhlédnutí: 1 347
Video
Revascularization: techniques,hardwares &procedures in PCI. 2021ACC/AHA/SCAI guidelines
zhlédnutí 476Před 2 lety
Procedures & Techniques of PCI. 2021 ACC/AHA/SCAI guidelines. A discussion on Vascular access, stent types, Thrombectomy, CTO PCI, ISR, SVG - PCI, Hemodynamic Support for #PCI and many such topics. We have been discussing the 2021 #coronary revascularization guidelines given by #ACC. This is the 6th and the last video in this series. in this video we discuss about the following Vascular Access ...
Revascularization in special situations.2021 ACC/AHA/SCAI GUIDELINES
zhlédnutí 636Před 2 lety
Revascularization in special situations - #pregnancy, old age, chronic kidney disease, cardiac allograft; revascularization to prevent ventricular tachycardia. Here is a discussion from 2021 ACC/AHA/SCAI GUIDELINES on Myocardial Revascularization. What to do in case of pregnancy? What to do in patients with #CKD? What to do in patients with old age? What to do in patients with ventricular tachy...
ANTIPLATELET THERAPY AFTER PCI. 2021 ACC/AHA/SCAI GUIDELINES
zhlédnutí 945Před 2 lety
ANTIPLATELET THERAPY BEFORE / DURING & AFTER PCI and CABG - 2021 ACC/AHA/SCAI GUIDELINES. A lot has changed in the field of Antiplatelet and antithrombotic therapy in patients undergoing #PCI or CABG. New evidence from trials like TWILIGHT trial, STOPDAPT trial, GLASSY & GLOBAL LEADER trial has made us reconsider what is optimal Antiplatelet Therapy for patients undergoing CABG and PCI. The new...
TOMAHAWK trial. Angiography after cardiac arrest
zhlédnutí 324Před 2 lety
TOMAHAWK trial or Angiography after Out-of-Hospital Cardiac Arrest without ST-Segment Elevation trial was recently published in #NEJM New England journal of Medicine and presented at the European Society of Cardiology Virtual Congress in 2021. It tested the strategy of immediate coronary angiography vs delayed or selective coronary angiography in patients with OHCA or Out of Hospital Cardiac Ar...
PARADISE MI trial. ARNI in acute MI NEJM 2021. ACC 2021
zhlédnutí 666Před 2 lety
PARADISE MI trial tested whether ARNI would be useful in acute MI. It was published in NEJM 2021and presented at ACC 2021. In the PARADISE MI trial patients of acute MI were randomised to receive ARNI or sacubitril/ valsartan and ramipril. in November 2021 this article came out in NEJM in print; it had alraedy been presented at ACC scientific meeting in May 2021. PARADISE MI trial was another l...
Revascularization - stable CAD. ACC/AHA/SCAI guidelines 2021
zhlédnutí 1,7KPřed 2 lety
Revascularization in stable CAD. ACC/AHA/SCAI guidelines 2021. Revascularization in stable CAD (coronary artery disease) had been a matter of debate in the field of Interventional Cardiology and cardiac surgery. What to do in patients with single vessel disease? What to do in patients with triple vessel disease? What to do in patients with Diabetes? Should the patients receive medical treatment...
Revascularization in NSTE-ACS. 2021 ACC/AHA/SCAI Guidelines
zhlédnutí 1,8KPřed 2 lety
Revascularization in NSTE- ACS (Non ST segment elevation acute coronary syndrome). 2021 ACC / AHA/ STS/ SCAI guidelines for myocardial revascularization -2. #AHA2021 #ACC2021 #SCAI2021 A discussion on every old and new concept in 2021 guidelines for myocardial revascularization. This was a huge 100 page document, so breaking it down for easier discussion into multiple parts. This is second of m...
Revascularization in STEMI. 2021 ACC/ AHA/ SCAI Guidelines
zhlédnutí 3,8KPřed 2 lety
Revascularization in STEMI. 2021 ACC/AHA/STS/SCAI guidelines for myocardial revascularization -I. A discussion on every old and new concept in 2021 guidelines for myocardial revascularization. This was a huge 100 page document, so breaking it down for easier discussion into multiple parts. This is first of many videos about to come on this document by ACC/AHA/SCAI. #Coronary #AHA2021 #americanh...
EMPULSE Trial. EMPAGLIFLOZIN in Acute Heart Failure. AHA2021
zhlédnutí 2,9KPřed 2 lety
EMPULSE TRIAL. EMPAGLIFLOZIN in patients with acute decompensated heart failure. EMPAGLIFLOZIN is one of the SGLT2 inhibitors. SGLT2 inhibitors are the new drugs which have been approved for heart failure with reduced ejection fraction (HFrEF). After the landmark EMPA-REG_OUTCOME, DECLARE TIMI 58, EMPEROR REDUCED and DAPA HF trials, empagliflozin and dapagliflozin have found a place in the mana...
FFR. Fractional Flow Reserve. Coronary Physiology for interventions.
zhlédnutí 2,3KPřed 2 lety
#FFR. Fractional Flow Reserve is useful for assessment and management of intermediate coronary lesions, left main interventions, multivessel disease and stable CAD. #FractionalFlowReserve. Here is a discussion on applications of Fractional Flow Reserve OR FFR in Interventional Cardiology and the various trials supporting the use of FFR - FAME trial, FAME 2 trial, DEFER trial, DANAMI 3 PRIMULTI ...
CHIEF HF Trial. CANAGLIFLOZIN in HEART FAILURE. AHA 2021
zhlédnutí 382Před 2 lety
CHIEF HF Trial was recently presented at the AHA 2021 meeting. It tested an #SGLT2Inhibitor #CANAGLIFLOZIN in #HEARTFAILURE. CHIEF HF Trial or CANAGLIFLOZIN in HEART FAILURE which was recently presented at AHA 2021 is yet to be published. If you were searching about CHIEF HF Trial or role of CANAGLIFLOZIN in HEART FAILURE you can find it in this video. The authors first presented its results in...
RAPID CABG trial. AHA 2021. Early CABG after ticagrelor.
zhlédnutí 185Před 2 lety
RAPID CABG Trial was recently presented at the AHA 2021. It tested the strategy of EARLY CABG AFTER TICAGRELOR vs delayed CABG after Ticagrelor administration. #AHA2021 #NEJM #heart #cardiacsurgery #cardiacsurgeon Follow Cardio-Ed for more content. m.czcams.com/channels/VxInTblTpoy-THMuSxNyvw.htmlvideos AVATAR trial. czcams.com/video/yVy2muQkOyA/video.html REVERSE IT trial czcams.com/video/gdQH...
Tricuspid repair in Mitral Valve surgery patients. AHA 2021
zhlédnutí 153Před 2 lety
CTCR - MVS trial was recently presented at the AHA 2021 and published in NEJM in November 2021. The trial was titled Tricuspid valve repair in patients undergoing Mitral Valve surgery. The CTCR - MVS trial tested whether Tricuspid valve repair in patients undergoing Mitral Valve surgery is helpful in these patients. AHA 2021. NEJM 2021. CTCR - MVS trial had 2 arms. one arm had Tricuspid valve r...
AVATAR Trial. Aortic valve surgery in Asymptomatic Severe Aortic Stenosis. AHA-2021
zhlédnutí 432Před 2 lety
AVATAR Trial. Aortic valve surgery in Asymptomatic Severe Aortic Stenosis. AHA-2021
REVERSE - IT Trial. Bentracimab for Ticagrelor reversal. AHA 2021.
zhlédnutí 166Před 2 lety
REVERSE - IT Trial. Bentracimab for Ticagrelor reversal. AHA 2021.
Revascularization in Stable Coronary Artery Disease. Lessons from ISCHEMIA, COURAGE, FREEDOM, ORBITA
zhlédnutí 516Před 2 lety
Revascularization in Stable Coronary Artery Disease. Lessons from ISCHEMIA, COURAGE, FREEDOM, ORBITA
ISCHEMIA trial Vs Contemporary PCI practice. JACC Interventions.
zhlédnutí 121Před 2 lety
ISCHEMIA trial Vs Contemporary PCI practice. JACC Interventions.
FAME 3 Trial. FFR guided PCI Vs CABG in three vessel CAD
zhlédnutí 1,8KPřed 2 lety
FAME 3 Trial. FFR guided PCI Vs CABG in three vessel CAD
EMPEROR PRESERVED trial. Empagliflozin in HFpEF patients.
zhlédnutí 1,8KPřed 2 lety
EMPEROR PRESERVED trial. Empagliflozin in HFpEF patients.
Device related thrombosis after LA appendage occlusion.
zhlédnutí 222Před 3 lety
Device related thrombosis after LA appendage occlusion.
Abelacimab for prevention of venous thromboembolism. NEJM 2021
zhlédnutí 952Před 3 lety
Abelacimab for prevention of venous thromboembolism. NEJM 2021
ADAPTABLE trial. Aspirin dose for secondary prevention.
zhlédnutí 227Před 3 lety
ADAPTABLE trial. Aspirin dose for secondary prevention.
REHAB- HF trial. Late breaking trial ACC 2021. NEJM 2021
zhlédnutí 185Před 3 lety
REHAB- HF trial. Late breaking trial ACC 2021. NEJM 2021
GALACTIC - HF & OMECAMTIV MECARBIL. JACC 2021. NEJM 2021
zhlédnutí 775Před 3 lety
GALACTIC - HF & OMECAMTIV MECARBIL. JACC 2021. NEJM 2021
In stent restenosis - Risk factors, pathology, identification and management
zhlédnutí 5KPřed 3 lety
In stent restenosis - Risk factors, pathology, identification and management
Therapeutic Hypothermia after cardiac arrest - TTM-2 trial
zhlédnutí 1,2KPřed 3 lety
Therapeutic Hypothermia after cardiac arrest - TTM-2 trial
Sound on this video is horrible! Impossible for me to hear with booming background sound!
SGLT2 inhibitor Jardiance truly works and reduced blood sugar to desired levels and have no serious side effects. It is a good invention.
Excellent review.
Terrific info. My life totally changer after being prescribed Forxiga. I would be thrilled to spread the word that heart failure symptoms can be reduced.
Can I ask what dose of FARXIGA do you take? Also how soon after taking it did not notice improvement and finally did it improve your ejection fraction? Thank you
Thank You for this information!
Excellent presentation . Thank you
Thank You for this VIDEO!!
need more of your videos
great
Asslam o alikum, could you please discuss 2022 recent guidelines of aortic diseases ?
Excellent
👍
It's really informative and helpful sir 👍👍
Plz add more studies sir 🙏
Very nice presentation sir
Please sir add more trials to your channel as I m having DNB exam in june22 and this channel is very useful to me and my friends
Sorry, i did not see the comment. I hope you do well in your exams. Going to make more videos soon.
Very nice Chanel sir very useful for DNB and dm going students
DNB means?
How to get this medication sir? My father was diagnosed diastolic heart failure.
Gr8
Can you please share link of particular article because it’s very difficult to find such information from AHA website
Sorry for the late reply. Here is the link to the entire article www.ahajournals.org/doi/10.1161/CIR.0000000000001038#
Bro u r doing a great job..but one advice please,u wont gather audience unti nd unless u dont Teach...what u r doing is Just Reading which one can do from a Book too
Question: Are SGLT2 inhibitors suitable for someone with HF and late stage 3 CKD with metabolic acidosis while on insulin therapy?
Why not try? I could barely get out of bed. My BNP is now normal. I can walk again.
Jinko stant dala h wey y goli kha sakte h kya
subtitles pleasee
turn on subtitles please
Done
Thanks Greatly
Great effort !! Preparing for my exam . Helped alot . If you can review other recent trials it will be great. 2020/2021...
Will do it.
Excellent presentation, thank you very much, you have one more follower, you are an example to follow, thanks for the effort of reviewing the evidence and providing us with the information.
This is the Channel i was always looking for!!!! So happy and Greetings From Germany
Thank you buddy.
Excellent
buenas tardes, me podria compartir el articulo por favor....
I have the article. Let me know if you need it.
@@CardioEd hello, can you send me the article??
Pls give me your email address
excellent review, thank you for your effort in reading the whole study and summarizing for us
Very nice analysis… 1 doubt, STITCH trial- Can we say that CABG Improves outcomes in patients with ischemic cardiomyopathy irrespective of viability..?
Yes. Thats what the trial says. Here is the link to the 10 years follow up data. www.nejm.org/doi/full/10.1056/NEJMoa1807365 - CABG plus medical therapy was associated with a lower incidence of death from any cause than medical therapy alone. - No significant interaction was observed between the presence or absence of myocardial viability and the beneficial effect of CABG plus medical therapy over medical therapy alone . - The findings of this study do not support the concept that myocardial viability is associated with a long-term benefit of CABG in patients with ischemic cardiomyopathy
Trials are discussed here- Ischemia Trial Courage Trial STITCH traial Orbita Trial Freedom Trial
💗💗💗💗
Nice
Thank you
Thanks shailesh
Nice presentation
Thank you.
And useful
Very crisp
Thank you.
Tough topic..so well covered!!
Tougher portions - Diagnosis/ Pathophysiology coming soon. 🤗
Very informative talk for cardiology practicing doc's 👏👍👌
Good learning for both cardiology fellows as well as for the practicing cardiologists!!
Very informative! With proper references and appropriate explanation!
Very informative lesson. Please also do a video on Mucormycosis. 🙏🏻 Thank you!
Will do
A lot of evidence based information about VTE prophylaxis! Thank you doc!